Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
| Revenue (TTM) | $458.69M |
| Gross Profit (TTM) | $296.10M |
| EBITDA | $61.40M |
| Operating Margin | 5.18% |
| Return on Equity | 3.14% |
| Return on Assets | 2.84% |
| Revenue/Share (TTM) | $9.80 |
| Book Value | $9.29 |
| Price-to-Book | 2.42 |
| Price-to-Sales (TTM) | 2.38 |
| EV/Revenue | 2.818 |
| EV/EBITDA | 19.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.50% |
| Shares Outstanding | $48.54M |
| Float | $46.01M |
| % Insiders | 4.64% |
| % Institutions | 93.44% |
Volatility is currently contracting